SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-061038
Filing Date
2023-07-31
Accepted
2023-07-31 09:30:40
Documents
16
Period of Report
2023-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182578-8k_abvcbio.htm   iXBRL 8-K 28670
2 OPINION OF HUNTER TAUBMAN FISCHER & LI LLC ea182578ex5-1_abvcbio.htm EX-5.1 24279
3 PRESS RELEASE DATED JULY 31, 2023 ea182578ex99-1_abvcbio.htm EX-99.1 13571
4 GRAPHIC ex5-1_001.jpg GRAPHIC 6882
5 GRAPHIC ex99-1_001.jpg GRAPHIC 5654
  Complete submission text file 0001213900-23-061038.txt   268720

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20230731.xsd EX-101.SCH 3021
7 XBRL LABEL FILE abvc-20230731_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE abvc-20230731_pre.xml EX-101.PRE 22363
10 EXTRACTED XBRL INSTANCE DOCUMENT ea182578-8k_abvcbio_htm.xml XML 3216
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231125304
SIC: 2834 Pharmaceutical Preparations